代谢功能障碍相关脂肪性肝病与CKD人群肾衰竭风险相关
该研究基于韩国NHIS数据库187,881例CKD个体,按脂肪性肝病类型分组,采用Cox比例风险模型分析肾衰竭风险。中位随访9.28年发生7,497例肾衰竭(4%)。
要点
- CKD人群中MASLD与肾衰竭风险独立相关,HR为1.146。
- 女性、老年、无高血压、无白蛋白尿及不吸烟亚组关联更显著。
- MASLD合并酒精摄入增加未显示肾衰竭风险显著升高。
核心结论
- 在CKD人群中,MASLD与肾衰竭风险显著相关。
- MASLD合并酒精摄入增加或特定病因脂肪性肝病与肾衰竭无显著关联。
研究设计与样本
- 基于韩国NHIS数据库医疗筛查数据的回顾性观察性队列研究。
- 纳入187,881例CKD个体,平均年龄63.3岁,女性占58%。
- 按脂肪性肝病类型分为无脂肪性肝病、MASLD、MASLD伴酒精摄入增加、酒精性肝病或特定病因脂肪性肝病四组。
- 采用Cox比例风险模型调整人口学和临床变量分析肾衰竭风险。
主要发现
- 中位随访9.28年(IQR 9.03-9.63)共发生7,497例肾衰竭事件(4%)。
临床怎么用
- 在CKD患者中应评估MASLD以识别肾衰竭高风险个体。
- 对合并MASLD的CKD患者,尤其女性、老年、无高血压、无白蛋白尿及不吸烟者,需加强风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although fatty liver disease is a known risk factor for chronic kidney disease (CKD), its association with kidney failure remains unclear, especially after its redefinition as metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to quantify the association between MASLD and kidney failure in the CKD population by generating epidemiological data. METHODS: We used 187,881 individuals with CKD from medical screening data of the National Health Insurance Service (NHIS) database of Korea. The population was categorized with no steatotic liver disease, MASLD, MASLD with increased alcohol intake, and alcoholic liver disease or steatotic liver disease with other specific etiologies. The risk of kidney failure was analyzed using Cox proportional hazard models adjusting demographic and clinical variables. RESULTS: The study population had mean age of 63.3 years with 58% females. During the median of 9.28 (9.03-9.63) years of follow-up, 7497 (4%) events of kidney failure were identified. In the adjusted model, the "MASLD" group showed higher risk of kidney failure (hazard ratio [HR]: 1.146 [1.078- 1.219]) compared with "no steatotic liver disease." However, "MASLD with increased alcohol intake" ([HR 0.981 [0.834-1.154]) or "alcoholic liver disease or steatotic liver disease with other specific etiologies" (HR 1.098, [0.991-1.216]) showed nonsignificant difference. The association between MASLD and kidney failure was particularly accentuated in females (HR 1.301 [(1.192-1.420]), old age, nonhypertension, nonalbuminuria, and nonsmoking subgroup. CONCLUSION: In this large-scale observational study, MASLD was associated with kidney failure in individuals with CKD. Our findings highlight the importance of risk stratification in certain patients to prevent kidney failure.
引用
- Kwon JK, Kim M, Lee J, et al. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease and Kidney Failure in the CKD Population. Kidney Int Rep. 2026. PMID: 41939218. doi:10.1016/j.ekir.2026.106414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。